{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/N",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Nervov\u00FD syst\u00E9m" , "@language" : "cs" } ,        { "@value" : "NERVOUS SYSTEM" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N05",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "PSYCHOLEPTICS" , "@language" : "en" } ,        { "@value" : "Psycholeptika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N05" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N05A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Antipsychotika, neuroleptika" , "@language" : "cs" } ,        { "@value" : "ANTIPSYCHOTICS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N05A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N05AX",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Other antipsychotics" , "@language" : "en" } ,        { "@value" : "Jin\u00E1 antipsychotika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N05AX" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N05AX08",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/N" ,        "http://linked.opendata.cz/resource/ATC/N05AX" ,        "http://linked.opendata.cz/resource/ATC/N05" ,        "http://linked.opendata.cz/resource/ATC/N05A" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Risperidon" , "@language" : "cs" } ,        { "@value" : "Risperidone" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N05AX08" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028338",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Risperidone" , "@language" : "en" } ,        { "@value" : "Risperidon" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0027734" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0021770" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0019685" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/MEDORISPER-0-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028338" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORISPER 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/N05AX08" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0102961" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0102962" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0102963" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0019685",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Serotonin - antagonist\u00E9" , "@language" : "cs" } ,        { "@value" : "Serotonin antagonists" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0021770",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antipsychotic agents" , "@language" : "en" } ,        { "@value" : "Antipsychotika" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0027734",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Dopamin - antagonist\u00E9" , "@language" : "cs" } ,        { "@value" : "Dopamine antagonists" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0102961",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORISPER 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/N05AX08" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIPSYCHOTICA (NEUROLEPTICA)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC161988_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0,5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "MEDORISPER je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B schizofrenie.\nMEDORISPER je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B st\u0159edn\u011B z\u00E1va\u017En\u00FDch a\u017E z\u00E1va\u017En\u00FDch manick\u00FDch epizod prov\u00E1zej\u00EDc\u00EDch bipol\u00E1rn\u00ED poruchy.\nMEDORISPER je indikov\u00E1n ke kr\u00E1tkodob\u00E9 l\u00E9\u010Db\u011B (do 6 t\u00FDdn\u016F) p\u0159etrv\u00E1vaj\u00EDc\u00ED agrese u\u00A0pacient\u016F se st\u0159edn\u011B z\u00E1va\u017Enou a\u017E z\u00E1va\u017Enou Alzheimerovskou demenc\u00ED, kte\u0159\u00ED neodpov\u00EDdaj\u00ED na nefarmakologick\u00E9 postupy a u\u00A0kter\u00FDch hroz\u00ED riziko sebepo\u0161kozen\u00ED nebo po\u0161kozen\u00ED ostatn\u00EDch.\nMEDORISPER je indikov\u00E1n ke kr\u00E1tkodob\u00E9 symptomatick\u00E9 l\u00E9\u010Db\u011B (a\u017E do 6 t\u00FDdn\u016F) p\u0159etrv\u00E1vaj\u00EDc\u00ED agrese p\u0159i poruch\u00E1ch chov\u00E1n\u00ED u\u00A0d\u011Bt\u00ED od 5 let v\u011Bku a\u00A0mladistv\u00FDch s\u00A0podpr\u016Fm\u011Brn\u00FDmi intelektu\u00E1ln\u00EDmi funkcemi nebo ment\u00E1ln\u00ED retardac\u00ED diagnostikovan\u00FDmi na z\u00E1klad\u011B DSM-IV krit\u00E9ri\u00ED, u\u00A0kter\u00FDch z\u00E1va\u017Enost agresivity nebo jin\u00E9 formy destruktivn\u00EDho chov\u00E1n\u00ED vy\u017Eaduj\u00ED farmakologickou l\u00E9\u010Dbu. Farmakologick\u00E1 l\u00E9\u010Dba mus\u00ED b\u00FDt sou\u010D\u00E1st\u00ED rozs\u00E1hl\u00E9ho l\u00E9\u010Debn\u00E9ho programu, kter\u00FD zahrne i\u00A0psychosoci\u00E1ln\u00ED a\u00A0vzd\u011Bl\u00E1vac\u00ED intervence. Doporu\u010Duje se, aby byl risperidon p\u0159edeps\u00E1n specialistou v\u00A0d\u011Btsk\u00E9 neurologii a\u00A0psychiatrem pro d\u011Bti a\u00A0mladistv\u00E9 nebo l\u00E9ka\u0159em, kter\u00FD je dob\u0159e sezn\u00E1men s\u00A0l\u00E9\u010Dbou disruptivn\u00EDch poruch chov\u00E1n\u00ED u\u00A0d\u011Bt\u00ED a\u00A0mladistv\u00FDch.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 52.66999816894531 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 66.16999816894531 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 20X0,5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0102962",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORISPER 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/N05AX08" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIPSYCHOTICA (NEUROLEPTICA)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC161988_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0,5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "MEDORISPER je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B schizofrenie.\nMEDORISPER je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B st\u0159edn\u011B z\u00E1va\u017En\u00FDch a\u017E z\u00E1va\u017En\u00FDch manick\u00FDch epizod prov\u00E1zej\u00EDc\u00EDch bipol\u00E1rn\u00ED poruchy.\nMEDORISPER je indikov\u00E1n ke kr\u00E1tkodob\u00E9 l\u00E9\u010Db\u011B (do 6 t\u00FDdn\u016F) p\u0159etrv\u00E1vaj\u00EDc\u00ED agrese u\u00A0pacient\u016F se st\u0159edn\u011B z\u00E1va\u017Enou a\u017E z\u00E1va\u017Enou Alzheimerovskou demenc\u00ED, kte\u0159\u00ED neodpov\u00EDdaj\u00ED na nefarmakologick\u00E9 postupy a u\u00A0kter\u00FDch hroz\u00ED riziko sebepo\u0161kozen\u00ED nebo po\u0161kozen\u00ED ostatn\u00EDch.\nMEDORISPER je indikov\u00E1n ke kr\u00E1tkodob\u00E9 symptomatick\u00E9 l\u00E9\u010Db\u011B (a\u017E do 6 t\u00FDdn\u016F) p\u0159etrv\u00E1vaj\u00EDc\u00ED agrese p\u0159i poruch\u00E1ch chov\u00E1n\u00ED u\u00A0d\u011Bt\u00ED od 5 let v\u011Bku a\u00A0mladistv\u00FDch s\u00A0podpr\u016Fm\u011Brn\u00FDmi intelektu\u00E1ln\u00EDmi funkcemi nebo ment\u00E1ln\u00ED retardac\u00ED diagnostikovan\u00FDmi na z\u00E1klad\u011B DSM-IV krit\u00E9ri\u00ED, u\u00A0kter\u00FDch z\u00E1va\u017Enost agresivity nebo jin\u00E9 formy destruktivn\u00EDho chov\u00E1n\u00ED vy\u017Eaduj\u00ED farmakologickou l\u00E9\u010Dbu. Farmakologick\u00E1 l\u00E9\u010Dba mus\u00ED b\u00FDt sou\u010D\u00E1st\u00ED rozs\u00E1hl\u00E9ho l\u00E9\u010Debn\u00E9ho programu, kter\u00FD zahrne i\u00A0psychosoci\u00E1ln\u00ED a\u00A0vzd\u011Bl\u00E1vac\u00ED intervence. Doporu\u010Duje se, aby byl risperidon p\u0159edeps\u00E1n specialistou v\u00A0d\u011Btsk\u00E9 neurologii a\u00A0psychiatrem pro d\u011Bti a\u00A0mladistv\u00E9 nebo l\u00E9ka\u0159em, kter\u00FD je dob\u0159e sezn\u00E1men s\u00A0l\u00E9\u010Dbou disruptivn\u00EDch poruch chov\u00E1n\u00ED u\u00A0d\u011Bt\u00ED a\u00A0mladistv\u00FDch.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 50X0,5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0102963",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MEDORISPER 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/N05AX08" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIPSYCHOTICA (NEUROLEPTICA)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC161988_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "60" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0,5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "MEDORISPER je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B schizofrenie.\nMEDORISPER je indikov\u00E1n k\u00A0l\u00E9\u010Db\u011B st\u0159edn\u011B z\u00E1va\u017En\u00FDch a\u017E z\u00E1va\u017En\u00FDch manick\u00FDch epizod prov\u00E1zej\u00EDc\u00EDch bipol\u00E1rn\u00ED poruchy.\nMEDORISPER je indikov\u00E1n ke kr\u00E1tkodob\u00E9 l\u00E9\u010Db\u011B (do 6 t\u00FDdn\u016F) p\u0159etrv\u00E1vaj\u00EDc\u00ED agrese u\u00A0pacient\u016F se st\u0159edn\u011B z\u00E1va\u017Enou a\u017E z\u00E1va\u017Enou Alzheimerovskou demenc\u00ED, kte\u0159\u00ED neodpov\u00EDdaj\u00ED na nefarmakologick\u00E9 postupy a u\u00A0kter\u00FDch hroz\u00ED riziko sebepo\u0161kozen\u00ED nebo po\u0161kozen\u00ED ostatn\u00EDch.\nMEDORISPER je indikov\u00E1n ke kr\u00E1tkodob\u00E9 symptomatick\u00E9 l\u00E9\u010Db\u011B (a\u017E do 6 t\u00FDdn\u016F) p\u0159etrv\u00E1vaj\u00EDc\u00ED agrese p\u0159i poruch\u00E1ch chov\u00E1n\u00ED u\u00A0d\u011Bt\u00ED od 5 let v\u011Bku a\u00A0mladistv\u00FDch s\u00A0podpr\u016Fm\u011Brn\u00FDmi intelektu\u00E1ln\u00EDmi funkcemi nebo ment\u00E1ln\u00ED retardac\u00ED diagnostikovan\u00FDmi na z\u00E1klad\u011B DSM-IV krit\u00E9ri\u00ED, u\u00A0kter\u00FDch z\u00E1va\u017Enost agresivity nebo jin\u00E9 formy destruktivn\u00EDho chov\u00E1n\u00ED vy\u017Eaduj\u00ED farmakologickou l\u00E9\u010Dbu. Farmakologick\u00E1 l\u00E9\u010Dba mus\u00ED b\u00FDt sou\u010D\u00E1st\u00ED rozs\u00E1hl\u00E9ho l\u00E9\u010Debn\u00E9ho programu, kter\u00FD zahrne i\u00A0psychosoci\u00E1ln\u00ED a\u00A0vzd\u011Bl\u00E1vac\u00ED intervence. Doporu\u010Duje se, aby byl risperidon p\u0159edeps\u00E1n specialistou v\u00A0d\u011Btsk\u00E9 neurologii a\u00A0psychiatrem pro d\u011Bti a\u00A0mladistv\u00E9 nebo l\u00E9ka\u0159em, kter\u00FD je dob\u0159e sezn\u00E1men s\u00A0l\u00E9\u010Dbou disruptivn\u00EDch poruch chov\u00E1n\u00ED u\u00A0d\u011Bt\u00ED a\u00A0mladistv\u00FDch.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 158.1199951171875 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 198.5200042724609 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL FLM 60X0,5MG" , "@language" : "cs" } ] }] }